Hamps Bio schedules AGM to approve office shift, director re-appointment

1 min read     Updated on 17 Aug 2026, 09:04 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Hamps Bio Limited holds its 19th AGM on September 9, 2026, to adopt FY26 results and re-appoint director Pallavi Herrik Shah. A special resolution seeks approval to shift the registered office from Ankleshwar to Surat for operational efficiency. Remote e-voting opens on September 6.

powered bylight_fuzz_icon
48526461

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited has scheduled its 19th Annual General Meeting (AGM) for Wednesday, September 9, 2026, at 12:00 pm. The meeting will be held at the company’s registered office located at 2900/112, G.I.D.C., near Atul Limited, Bharuch, Ankleshwar, Gujarat.

The agenda for the meeting includes ordinary business such as the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. Additionally, shareholders will consider the re-appointment of Mrs. Pallavi Herrik Shah as a director, who retires by rotation and is eligible for re-appointment.

Special Resolution: Registered Office Shift

A key item on the agenda is a special resolution to approve the shifting of the company’s registered office from Ankleshwar to Surat. Both locations are within the state of Gujarat and under the jurisdiction of the same Registrar of Companies, Ahmedabad.

Current Address Proposed Address
2900/112, G.I.D.C., Near Atul Limited, Bharuch, Ankleshwar, Gujarat 393002 Plot No C1-B-106, Nr Mama Bhanja Factory, Bhatpore GIDC, Bhatpore, Surat, Choryasi, Gujarat 394510

The Board of Directors stated that the move aims to carry on business more economically and efficiently with better operational convenience. The shift requires member approval via a special resolution pursuant to Section 12 of the Companies Act, 2013.

Director Re-appointment Details

Mrs. Pallavi Herrik Shah, currently serving as a director, seeks re-appointment. She holds a Bachelor of Pharmacy degree from Pune University (2002) and has expertise in administrative management and pharma/FMCG team analysis. As per disclosures, she holds 294,714 shares in the company. She is related to Mr. Herrik Mountbaton Shah (Chairman and Managing Director) and Mr. Shrenikkumar Mountkumar Shah (Director).

E-Voting and Logistics

Remote e-voting will commence on Sunday, September 6, 2026, at 9:00 am and conclude on Tuesday, September 8, 2026, at 5:00 pm. The record date for voting eligibility is Friday, September 3, 2026. Shareholders holding securities in demat mode can vote through their depository participants or directly via the Bigshare e-voting platform. Physical shareholders must use their folio numbers for login credentials.

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
-6.12%-5.66%-5.15%+22.28%-20.44%-54.79%

How might the relocation of the registered office to Surat impact Hamps Bio's operational costs and supply chain logistics in the coming fiscal years?

What are the potential tax or regulatory implications for shareholders resulting from the shift of the registered office within Gujarat?

Will the re-appointment of Mrs. Pallavi Herrik Shah signal any upcoming changes in corporate governance or strategic direction given her familial ties to the leadership?

Hamps Bio appoints Ravi Baheti as Company Secretary and Compliance Officer

1 min read     Updated on 06 Jul 2026, 10:57 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Hamps Bio Limited has appointed Mr. Ravi Baheti as Company Secretary and Compliance Officer effective July 6, 2026, following the resignation of Ms. Komal Jain effective June 30, 2026. The Board approved the changes to ensure governance continuity, complying with SEBI regulations.

powered bylight_fuzz_icon
44373674

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited has appointed Mr. Ravi Baheti as its Company Secretary and Compliance Officer, effective July 6, 2026. This decision follows the resignation of Ms. Komal Jain from the same position, which was effective from the close of business hours on June 30, 2026. The Board approved these changes during its meeting held on July 6, 2026, to ensure continuity in the company's compliance and governance functions.

The resignation of Ms. Jain was attributed to personal reasons, and she confirmed there were no other material factors for her departure. The company disclosed these details in a filing submitted to BSE Limited, complying with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Managing Director Herrick Mountbaton Shah.

Details of Appointment

Mr. Baheti brings over nine years of experience in secretarial work to the role. He is an Associate Member of the Institute of Company Secretaries of India (ICSI), holding Membership No. A49472, and possesses a Bachelor's degree in Commerce (Hons). His expertise includes corporate governance, drafting, compliance management, and other allied secretarial functions.

Particulars Remarks
Reason for change Appointment of Mr. Ravi Baheti as a Company Secretary and Compliance Officer.
Date of Appointment W.e.f 06th July, 2026
Brief Profile Associate Member of ICSI (Membership No. A49472). Holds B.Com (Hons). Over 9 years of experience in secretarial work, corporate governance, and compliance.

Details of Cessation

The transition was formalized under the provisions of SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The Board also authorized Key Managerial Personnel (KMP) to determine the materiality of events or information for disclosures to the stock exchanges pursuant to Regulation 30(5) of the SEBI Listing Regulations.

Particulars Remarks
Reason for change Due to personal reason.
Date of Cessation Closing business hours of 30th June, 2026

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
-6.12%-5.66%-5.15%+22.28%-20.44%-54.79%

How will Mr. Baheti's appointment influence Hamps Bio's future compliance and governance strategies?

What impact might this leadership change have on the company's relationship with SEBI and BSE?

Could the transition in the compliance officer role lead to any shifts in Hamps Bio's disclosure practices?

More News on Hamps Bio

1 Year Returns:-20.44%